• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UGT1A1(TA)n启动子多态性——白种人中(TA)8等位基因的一个新病例。

UGT1A1(TA)n promoter polymorphism--a new case of a (TA)8 allele in Caucasians.

作者信息

Ostanek Barbara, Furlan Danijela, Mavec Tina, Lukac-Bajalo Jana

机构信息

University of Ljubljana, Faculty of Pharmacy, Department of Clinical Biochemistry, Askerceva 7, SI-1000 Ljubljana, Slovenia.

出版信息

Blood Cells Mol Dis. 2007 Mar-Apr;38(2):78-82. doi: 10.1016/j.bcmd.2006.10.160. Epub 2006 Dec 28.

DOI:10.1016/j.bcmd.2006.10.160
PMID:17196409
Abstract

Gilbert's syndrome is a mild hereditary unconjugated hyperbilirubinemia caused by mutations in the bilirubin UDP-glucuronosyltransferase gene (UGT1A1). The causative mutation in Caucasians is almost exclusively a TA dinucleotide insertion in the TATA box of the UGT1A1 promoter. Affected individuals are homozygous for the variant promoter and have 7 instead of 6 TA repeats. The aim of the present study was to determine the genotypes of UGT1A1(TA)n promoter polymorphism in the healthy Slovenian population and to investigate the association of genotypes with serum bilirubin levels. 236 healthy subjects were genotyped by single-strand conformation polymorphism analysis, which was validated by sequence analysis. The frequencies of genotypes were as follows: (TA)(6/6) (38.1%), (TA)(6/7) (47.9%), (TA)(7/7) (13.6%). There was a statistically significant association of genotypes with serum bilirubin levels (p<0.001). Subjects with genotype (TA)(7/7) had the highest and subjects with genotype (TA)(6/6) the lowest total serum bilirubin levels. One individual in the group had the rare genotype (TA)(7/8) (0.4%). Analysis of his family showed the following genotypes: (TA)(6/8) in his father and sister and (TA)(7/8) in his two brothers. In conclusion, the frequency of UGT1A1(TA)n promoter polymorphism genotypes was determined for the first time in the Slovenian population and is similar to frequencies observed in other Caucasian populations. The extremely rare (TA)8 allele in Caucasians was found also in Slovenians.

摘要

吉尔伯特综合征是一种由胆红素UDP - 葡萄糖醛酸基转移酶基因(UGT1A1)突变引起的轻度遗传性非结合胆红素血症。白种人中的致病突变几乎完全是UGT1A1启动子TATA框中的TA二核苷酸插入。受影响个体的变异启动子为纯合子,有7个而非6个TA重复序列。本研究的目的是确定健康斯洛文尼亚人群中UGT1A1(TA)n启动子多态性的基因型,并研究基因型与血清胆红素水平的关联。通过单链构象多态性分析对236名健康受试者进行基因分型,并通过序列分析进行验证。基因型频率如下:(TA)(6/6)(38.1%),(TA)(6/7)(47.9%),(TA)(7/7)(13.6%)。基因型与血清胆红素水平存在统计学显著关联(p<0.001)。基因型为(TA)(7/7)的受试者总血清胆红素水平最高,基因型为(TA)(6/6)的受试者最低。该组中有一名个体具有罕见的基因型(TA)(7/8)(0.4%)。对其家族的分析显示以下基因型:他的父亲和妹妹为(TA)(6/8),他的两个兄弟为(TA)(7/8)。总之,首次在斯洛文尼亚人群中确定了UGT1A1(TA)n启动子多态性基因型的频率,且与其他白种人群中观察到的数据相似。斯洛文尼亚人中也发现了白种人中极其罕见的(TA)8等位基因。

相似文献

1
UGT1A1(TA)n promoter polymorphism--a new case of a (TA)8 allele in Caucasians.UGT1A1(TA)n启动子多态性——白种人中(TA)8等位基因的一个新病例。
Blood Cells Mol Dis. 2007 Mar-Apr;38(2):78-82. doi: 10.1016/j.bcmd.2006.10.160. Epub 2006 Dec 28.
2
(TA)8 allele in the UGT1A1 gene promoter of a Caucasian with Gilbert's syndrome.一名患有吉尔伯特综合征的白种人UGT1A1基因启动子中的(TA)8等位基因。
Haematologica. 1999 Feb;84(2):106-9.
3
Development of a new DHPLC assay for genotyping UGT1A (TA)n polymorphism associated with Gilbert's syndrome.建立一种新的 DHPLC 分析方法用于检测 Gilbert 综合征相关 UGT1A(TA)n 多态性的基因型。
Biochem Med (Zagreb). 2011;21(2):167-73. doi: 10.11613/bm.2011.026.
4
Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene.人类肝脏胆红素UDP-葡萄糖醛酸基转移酶活性与UGT1A1基因启动子区域多态性的关联。
J Hepatol. 2000 Sep;33(3):348-51. doi: 10.1016/s0168-8278(00)80268-8.
5
UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations.白种人和亚洲人中尿苷二磷酸葡萄糖醛酸基转移酶(UGT1A1*28和UGT1A6*2)基因多态性:与血清胆红素浓度的关系
Pharmacogenetics. 1999 Jun;9(3):341-9. doi: 10.1097/00008571-199906000-00009.
6
Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood.胆红素UDP-葡萄糖醛酸基转移酶1A1(UGT1A1)基因启动子多态性与人血中次黄嘌呤磷酸核糖转移酶、血型糖蛋白A及微核突变频率
Mutat Res. 2004 May 9;560(1):1-10. doi: 10.1016/j.mrgentox.2004.01.010.
7
Restriction fragment length polymorphism effectively identifies exon 1 mutation of UGT1A1 gene in patients with Gilbert's Syndrome.限制性片段长度多态性可有效识别吉尔伯特综合征患者中UGT1A1基因的外显子1突变。
Liver Int. 2015 Aug;35(8):2050-6. doi: 10.1111/liv.12785. Epub 2015 Feb 6.
8
Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.与母乳及胆红素尿苷二磷酸葡萄糖醛酸转移酶基因突变相关的持续性非结合性高胆红素血症
Pediatrics. 2000 Nov;106(5):E59. doi: 10.1542/peds.106.5.e59.
9
Dependence of blood biochemical parameters on various genotypes of the UGT1A1 gene associated with gilbert's syndrome.血生化参数与吉尔伯特综合征相关的 UGT1A1 基因各种基因型的关系。
Klin Lab Diagn. 2022 Feb 23;67(2):69-75. doi: 10.51620/0869-2084-2022-67-2-69-75.
10
The combination of new missense mutation with [A(TA)7TAA] dinucleotide repeat in UGT1A1 gene promoter causes Gilbert's syndrome.UGT1A1基因启动子中新的错义突变与[A(TA)7TAA]二核苷酸重复序列相结合导致吉尔伯特综合征。
Ann Clin Lab Sci. 2015 Spring;45(2):202-5.

引用本文的文献

1
The Mutation Hotspots at UGT1A Locus May Be Associated with Gilbert's Syndrome Affecting the Taiwanese Population.UGT1A 基因座的突变热点可能与影响台湾人群的吉尔伯特综合征有关。
Int J Mol Sci. 2022 Oct 21;23(20):12709. doi: 10.3390/ijms232012709.
2
(TA) Promoter Genotype: Diagnostic and Population Pharmacogenetic Marker in Serbia.(TA)启动子基因型:塞尔维亚的诊断和群体药物遗传学标志物
Balkan J Med Genet. 2018 Oct 29;21(1):59-68. doi: 10.2478/bjmg-2018-0012. eCollection 2018 Jun.
3
Body fat percentage is a major determinant of total bilirubin independently of UGT1A1*28 polymorphism in young obese.
在年轻肥胖人群中,体脂百分比是总胆红素的主要决定因素,与UGT1A1*28基因多态性无关。
PLoS One. 2014 Jun 5;9(6):e98467. doi: 10.1371/journal.pone.0098467. eCollection 2014.
4
UGT1A1 gene variants and clinical risk factors modulate hyperbilirubinemia risk in newborns.UGT1A1 基因变异与临床危险因素调节新生儿高胆红素血症风险。
J Perinatol. 2014 Feb;34(2):120-4. doi: 10.1038/jp.2013.140. Epub 2013 Nov 14.
5
The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.UGT1A1 启动子多态性对血红蛋白病患者高胆红素血症和胆石症发展的影响。
PLoS One. 2013 Oct 30;8(10):e77681. doi: 10.1371/journal.pone.0077681. eCollection 2013.
6
Early complication in sickle cell anemia children due to A(TA)nTAA polymorphism at the promoter of UGT1A1 gene.由于 UGT1A1 基因启动子处的 A(TA)nTAA 多态性,镰状细胞贫血儿童的早期并发症。
Dis Markers. 2013;35(2):67-72. doi: 10.1155/2013/173474. Epub 2013 Jul 28.
7
Heme oxygenase-1 gene variants and hyperbilirubinemia risk in North Indian newborns.血红素加氧酶-1 基因变异与北印度新生儿高胆红素血症风险。
Eur J Pediatr. 2013 Dec;172(12):1627-32. doi: 10.1007/s00431-013-2091-7. Epub 2013 Jul 23.
8
Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.印度南部人群 TPMT、UGT1A1 和 MDR1 基因分子变异型的种间和种内分布差异。
Mol Biol Rep. 2012 May;39(5):6343-51. doi: 10.1007/s11033-012-1456-8. Epub 2012 Feb 9.
9
Effects of UGT1A1*28 polymorphism on raloxifene pharmacokinetics and pharmacodynamics.UGT1A1*28基因多态性对雷洛昔芬药代动力学和药效学的影响。
Br J Clin Pharmacol. 2009 Apr;67(4):437-44. doi: 10.1111/j.1365-2125.2009.03363.x.